Drug Side Effects
Search
PARANEOPLASTIC PLEURAL EFFUSION
PARANEOPLASTIC PLEURAL EFFUSION
was reported 24 times
PARANEOPLASTIC PLEURAL EFFUSION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Vitamin D3 Analog [EPC]
1
0.0000
1
BCL-2 Inhibitor [EPC]
3
0.0000
2
HER2/neu Receptor Antagonist [EPC]
3
0.0000
3
Programmed Death Receptor-1 Blocking Antibody [EPC]
3
0.0000
4
Nucleoside Metabolic Inhibitor [EPC]
6
0.0000
5
CTLA-4-directed Blocking Antibody [EPC]
1
0.0000
6
Topoisomerase Inhibitor [EPC]
1
0.0000
7
Nitrate Vasodilator [EPC]
1
0.0000
8
Opioid Agonist [EPC]
3
0.0000
9
CD20-directed Cytolytic Antibody [EPC]
3
0.0000
10
Dihydropyridine Calcium Channel Blocker [EPC]
3
0.0000
11
Kinase Inhibitor [EPC]
5
0.0000
12
Aromatase Inhibitor [EPC]
1
0.0000
13
Serotonin-3 Receptor Antagonist [EPC]
1
0.0000
14
Platinum-based Drug [EPC]
2
0.0000
15
Alkylating Drug [EPC]
1
0.0000
16
Platelet Aggregation Inhibitor [EPC]
2
0.0000
17
Vitamin D [EPC]
1
0.0000
18
Corticosteroid [EPC]
4
0.0000
19
Vitamin B12 [EPC]
1
0.0000
20
Vitamin C [EPC]
1
0.0000
21
Thalidomide Analog [EPC]
1
0.0000
22
Proton Pump Inhibitor [EPC]
1
0.0000
23
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000